Clinical Trials Logo

Abuse Potential clinical trials

View clinical trials related to Abuse Potential.

Filter by:
  • None
  • Page 1

NCT ID: NCT04570436 Not yet recruiting - Abuse Potential Clinical Trials

Evaluating the Abuse Potential of Neurontin® When Taken Orally in Healthy Non-drug Dependent Participants With Sedative Drug Abuse Experience

Start date: October 30, 2020
Phase: Phase 4
Study type: Interventional

This will be a randomized, double-blind, double-dummy, placebo- and active controlled, 5 treatment, 10 sequence, 5 period crossover single dose, Williams square design study in healthy adult, non drug dependent male and female participants with drug abuse experience with sedative drugs.

NCT ID: NCT03200080 Terminated - Abuse Potential Clinical Trials

A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users

Start date: September 18, 2017
Phase: Phase 1
Study type: Interventional

This will be a single-dose, randomized, double-blind, active- and placebo-controlled, double dummy, 6-way crossover study to determine the abuse potential of tozadenant relative to d-amphetamine and placebo, when administered orally in healthy non-dependent, recreational polydrug users with stimulant experience, under fed conditions. Each subject will participate in a medical Screening visit, a 4-day (3-night) qualification (drug discrimination) visit, six 3-day (2-night) treatment periods, and a follow-up visit.